This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Prefilled Syringes Drug Molecules Market

Market Insights on Prefilled Syringes Drug Molecules covering sales outlook, demand forecast & up-to-date key trends

Prefilled Syringes Drug Molecules Market by Drug Class (Vaccines, Insulin, Adrenaline, Opioids, Others), Application (Cardiovascular Diseases, Diabetes, Immunization, Pain Management, Others), End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores) & Region - Forecast 2022 - 2028

Prefilled Syringes Drug Molecules Market Outlook (2022-2028)

[306 Pages Report] The global Prefilled Syringes Drug Molecules Market is set to be valued at US$ 56 Bn in 2022, and is projected to expand at a CAGR of 5.6% to close in on a valuation of US$ 77.7 Bn by 2028.

Prefilled Syringes Drug Molecules Market Size (2022)

US$ 56 Bn

Prefilled Syringes Drug Molecules Sales Forecast (2028)

US$ 77.7 Bn

Global Market Growth Rate (2022 to 2028)

5.6% CAGR

Share of Top 5 Prefilled Syringes Drug Molecules Providers

55%

At present, sales of prefilled syringes drug molecules account for around 23% market share of the global drug delivery market. Demand for prefilled syringes drug molecules in online pharmacies is likely to increase at a CAGR of 6.2% over the assessment period of 2022 to 2028.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

5.69%

H1, 2022 Projected

5.59%

H1, 2022 Outlook

4.99%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 60 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 70 ↓

The comparative analysis and market growth rate of global prefilled syringes drug molecules market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 60 BPS, and, a decline in BPS values is expected in H1-2022 over H1- 2021 duration with 70 Basis Point Share (BPS).

The global prefilled syringes drug molecules market is subject to device regulations, biological safety assessment, approval of new biologics, and sustainable product development features, as per all the macro and industry standards.

The key developments in the market include the advancements in the parenteral administration of APIs, and the siliconization of pre-filled syringes to prevent the interaction of the API molecules with the syringe glass and to protect the drug integrity. The market is highly influenced by the rapid growth and development of novel biologics, and targeted molecular entities such as interferons, monoclonal antibodies, peptides, and vaccines.

The market decline observed through the reduction in the BPS values is addressed by the presence of reported cases of presence of extractables and leachables in the vials compromising the effectiveness of a drug. Moreover, associated similarly to drug integrity, the presence of product recall activities have further disrupted the market growth and is hence associated with the reduced BPS values.

Prefilled Syringes Drug Molecules Consumption Analysis (2012-2021) in Comparison to Market Outlook (2022-2028)

The global prefilled syringes drug molecules market witnessed a growth rate of 5.3% over the historical period of 2012 to 2028.

Prefilled syringes drug delivery is preferred over conventional vials as it comes with various benefits such as less over-filling as well as safe and convenient use, thus driving demand for prefilled syringes drug molecules.

Prefilled syringes drug delivery is convenient for those patients that require parenteral administration of drugs on a daily/weekly basis and long-term treatment. As such, they prefer self-administrated devices as they don’t have to remain dependent on doctors for each dosage.

Prefilled syringes provide inexpensive home setting medication and reduce time consumed at in-patient and out-patient care units. For patients requiring frequent dose administration on a weekly and daily basis, use of prefilled syringes drug molecules reduces the average cost per injection when compared to vials and ampoules.

Prefilled Syringes Drug Molecules Market Download Report Brochure

There is also a decrease in the reliance on healthcare professionals in many regions, and this is likely to boost the small molecule prefilled syringes market. Revenue growth of the market is mainly driven by the effectiveness, convenience, and ease of use of prefilled syringes. This has attracted various healthcare professionals and patients to use prefilled syringe products.

In addition, the minimal contamination of drug molecules and self-administration of drugs at home settings has increased demand for prefilled syringes drug molecules. Prefilled syringe manufacturers are focusing on introducing updated technologies and advanced prefilled syringe products to attract more customers.

Pharmaceutical companies are introducing generic versions for cost-effective auto-injector devices, and are targeting emerging regions to sustain and grow in the global prefilled syringes drug molecules market.

Overall, the global prefilled syringes drug molecules market is slated to surge at a CAGR of 5.6% from 2022 to 2028.

What Makes North America the Largest Regional Market for Prefilled Syringes Drug Molecules?

On the basis of region, North America is expected to lead the global market for prefilled syringes drug molecules. The North American regional market is expected to account for 30.6% share in 2022, closely followed by Western Europe.

Rising need for self-administered equipment for patients' regular prescription doses, breakthroughs in technology, well-developed pharmaceutical system, and growing adoption of auto-injector devices are driving market growth in the region.

Prefilled syringe manufacturers are being compelled to develop cost-effective auto-injector devices as a result of increased global investments in healthcare development, greater disposable income, and improving standard of life.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-wise Analysis

How is the U.S. Prefilled Syringes Drug Molecules Market Faring?

The U.S. prefilled syringes drug molecules market is flourishing as a result of rising lifestyle-related disorders and the growing desire for easy-to-administer injectables among chronic disease patients.

In the market, there is a huge concentration of vendors who sell both, end products and original components. Availability of qualified vendors ensures high usage of prefilled syringes in the United States.

Will Manufacturers of Prefilled Syringes Drug Molecules Gain Profits in China?

Increased pharmaceutical development, ageing population, healthcare innovations, and the highest number of diabetic patients are factors driving prefilled syringes drug molecules demand growth in China.

Prefilled syringe providers are concentrating their efforts in China to strengthen their positions in the global market. This is one of the areas where China is projected to see significant growth in the next few years.

Furthermore, China is predicted to rise significantly in the market over the forecast period as a result of market participants expanding their businesses by investing in new manufacturing facilities.

Category-wise Insights

Which Drug Class Will Hold Maximum Sway in Prefilled Syringes Drug Molecules?

On the basis of drug class, vaccines are anticipated to register the highest CAGR over the forecast period. Sales of vaccines are projected to increase 2.1X by 2028.

Vaccines are antigenic substances prepared from the causative agent of a disease or a synthetic substitute, used to provide immunity against one or several diseases. Vaccines stimulate the immune system to make antibodies in the same way that it does when a person is exposed to a disease.

Vaccination is a simple, safe, and efficient technique to protect oneself from deadly diseases before they infect. It strengthens the immune system by utilizing the body's own defences to create resistance to specific pathogens.

Due to the rapid production of coronavirus vaccines, the impact of COVID-19 on pharmaceutical packaging is projected to be significant. Growing adoption of prefilled syringes for vaccination purposes is set to fueling prefilled syringes drug molecules consumption over the coming years.

Which End User of Prefilled Syringes Drug Molecules Will Emerge as a Key Market Contributor?

In terms of end users, sales of prefilled syringes drug molecules through online pharmacies is projected to register a high growth rate of 6.2% over the forecast period.

Growing trend of self-care, which is fueled by the easy availability of technological gadgets that lessen the need for visits to healthcare professionals, is likely to stifle the growth of hospital pharmacies. Furthermore, online pharmacies assist individuals with chronic illnesses such as diabetes and allergies.

Patients who need to take regular injection doses prefer to get their prescriptions from online order pharmacies. This assists in lowering the total cost to the patient during the course of treatment. Products offered through online pharmacies must be created with the patient's comfort in mind.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Impact of COVID-19 on Prefilled Syringes Drug Molecules Demand Growth

The COVID-19 pandemic and subsequent lockdowns in several nations throughout the world have had a financial impact on enterprises in all sectors, including the healthcare sector.

The COVID-19 pandemic, which began in 2020, affected healthcare delivery all around the world, including delays in the needle or syringe-related diagnosis and treatment. As a result, the impact of COVID-19 restricted the growth of the global prefilled syringes drug molecules market. The pandemic has had an influence on the market, and the impact of the pandemic on medicine manufacturing and supply chain is projected to have a short-term impact on the market.

Because of the lower danger of needle-stick injuries, prefilled syringes are becoming more popular than glass ampoules or any other additional needles. As a result, producers are increasing their production capacity in order to scale up the production of the COVID-19 vaccine. Demand for prefilled syringe products has increased as a result of the COVID-19 pandemic.

Competitive Landscape

The global prefilled syringes drug molecules market is highly competitive due to the presence of well-established top players. However, prefilled syringes drug molecules brands such as EpiPen auto-injector and BD Physioject disposable auto-injector have strategically maintained their position in the market owing to a distinctive value proposition such as providing more precision and accurate dosages.

For instance,

  • In December 2020, BD (Becton, Dickinson and Company) decided to invest approximately US$ 1.2 Bn over the next four years to broaden and enhance its production capabilities and innovation for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) throughout its six global production sites, as well as to open a new assembly plant in Spain.

Prefilled Syringes Drug Molecules Industry Report Scope

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2012-2021

Market Analysis

Value in US$ Mn

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • U.S.
  • Canada
  • Mexico
  • Brazil
  • Mexico
  • Argentina
  • Germany
  • Italy
  • France
  • U.K
  • Nordic
  • Spain
  • Japan
  • China
  • India
  • Malaysia
  • Thailand
  • Australia
  • GCC Countries
  • South Africa
  • Turkey

Key Market Segments Covered

  • Drug Class
  • Application
  • End User
  • Region

Key Companies Profiled

  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • AstraZeneca plc
  • Mylan N.V.
  • Pfizer, Inc.
  • Fresenius Kabi AG
  • Johnson & Johnson
  • Sanofi
  • Merck & Co. Inc.
  • Novartis AG
  • McKesson Corporation

Pricing

Available upon Request

Key Segments of Prefilled Syringes Drug Molecules Industry Research

By Drug Class :

  • Vaccines
  • Insulin
  • Adrenaline
  • Opioids
  • Others

By Application :

  • Prefilled Syringes Drug Molecules for Cardiovascular Diseases
  • Prefilled Syringes Drug Molecules for Diabetes
  • Prefilled Syringes Drug Molecules for Immunization
  • Prefilled Syringes Drug Molecules for Pain Management
  • Others

By End User :

  • Prefilled Syringes Drug Molecules Sold at Hospital Pharmacies
  • Prefilled Syringes Drug Molecules Sold at Retail Pharmacies
  • Prefilled Syringes Drug Molecules Sold through Online Pharmacies
  • Prefilled Syringes Drug Molecules Sold at Drug Stores

By Region :

  • North America Prefilled Syringes Drug Molecules Market
  • Latin America Prefilled Syringes Drug Molecules Market
  • Europe Prefilled Syringes Drug Molecules Market
  • East Asia Prefilled Syringes Drug Molecules Market
  • South Asia & Pacific Prefilled Syringes Drug Molecules Market
  • Middle East & Africa (MEA) Prefilled Syringes Drug Molecules Market

Frequently Asked Questions

The global prefilled syringes drug molecules market is currently valued at around US$ 56 Bn.

Rising self-medication and digitalization as well as lower costs and increased efficiency of prefilled syringes are driving market growth.

North America is the largest and fastest-growing regional market for prefilled syringes drug molecules at an expected CAGR of 6.2% over the forecast period.

Amgen Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Mylan N.V., and Pfizer, Inc. are identified as leading providers of prefilled syringes drug molecules.

Vaccines account for 50% share of the prefilled syringes drug molecules industry.

The global prefilled syringes drug molecules market is expected to exhibit a CAGR of 5.6% over the forecast period (2022-2028).

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

3. Prefilled Syringes Drug Molecules Market View Point

    3.1. Macro-Economic Factors

    3.2. Opportunity Analysis

4. North America Prefilled Syringes Drug Molecules Market Analysis 2012–2021 and Forecast 2022–2028

    4.1. Introduction

    4.2. Regional Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Trends

    4.3. Historical Market Size (US$ Mn) By Country, 2012-2021

        4.3.1. U.S.

        4.3.2. Canada

    4.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

        4.4.1. U.S.

        4.4.2. Canada

    4.5. Historical Market Size (US$ Mn) By Drug Class, 2012–2021

        4.5.1. Vaccines

        4.5.2. Insulin

        4.5.3. Adrenaline

        4.5.4. Opioids

        4.5.5. Others

    4.6. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028

        4.6.1. Vaccines

        4.6.2. Insulin

        4.6.3. Adrenaline

        4.6.4. Opioids

        4.6.5. Others

    4.7. Historical Market Size (US$ Mn) Analysis By Application , 2012-2021

        4.7.1. Cardiovascular Diseases

        4.7.2. Diabetes

        4.7.3. Immunization

        4.7.4. Pain Management

        4.7.5. Others

    4.8. Market Size (US$ Mn) Forecast By Application , 2022-2028

        4.8.1. Cardiovascular Diseases

        4.8.2. Diabetes

        4.8.3. Immunization

        4.8.4. Pain Management

        4.8.5. Others

    4.9. Historical Market Size (US$ Mn) Analysis By End User, 2012–2021

        4.9.1. Hospital Pharmacies

        4.9.2. Retail Pharmacies

        4.9.3. Online Pharmacies

        4.9.4. Drug stores

    4.10. Market Size (US$ Mn) Forecast By End User, 2022–2028

        4.10.1. Hospital Pharmacies

        4.10.2. Retail Pharmacies

        4.10.3. Online Pharmacies

        4.10.4. Drug stores

    4.11. Drivers and Restraints: Impact Analysis

    4.12. Market Attractiveness Analysis

        4.12.1. By Country

        4.12.2. By Drug Class

        4.12.3. By Application

        4.12.4. By End User

    4.13. Key Representative Market Participants

    4.14. Key Participants Market Presence (Intensity Map)

5. Latin America Prefilled Syringes Drug Molecules Market Analysis 2012–2021 and Forecast 2022–2028

    5.1. Introduction

    5.2. Regional Market Dynamics

        5.2.1. Drivers

        5.2.2. Restraints

        5.2.3. Trends

    5.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        5.3.1. Brazil

        5.3.2. Mexico

        5.3.3. Rest of Latin America

    5.4. Market Size (US$ Mn) Forecast By Country, 2022–2028

        5.4.1. Brazil

        5.4.2. Mexico

        5.4.3. Rest of Latin America

    5.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012–2021

        5.5.1. Vaccines

        5.5.2. Insulin

        5.5.3. Adrenaline

        5.5.4. Opioids

        5.5.5. Others

    5.6. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028

        5.6.1. Vaccines

        5.6.2. Insulin

        5.6.3. Adrenaline

        5.6.4. Opioids

        5.6.5. Others

    5.7. Historical Market Size (US$ Mn) Analysis By Application , 2012-2021

        5.7.1. Cardiovascular Diseases

        5.7.2. Diabetes

        5.7.3. Immunization

        5.7.4. Pain Management

        5.7.5. Others

    5.8. Market Size (US$ Mn) Forecast By Application , 2022-2028

        5.8.1. Cardiovascular Diseases

        5.8.2. Diabetes

        5.8.3. Immunization

        5.8.4. Pain Management

        5.8.5. Others

    5.9. Historical Market Size (US$ Mn) Analysis By End User, 2012–2021

        5.9.1. Hospital Pharmacies

        5.9.2. Retail Pharmacies

        5.9.3. Online Pharmacies

        5.9.4. Drug stores

    5.10. Market Size (US$ Mn) Forecast By End User, 2022–2028

        5.10.1. Hospital Pharmacies

        5.10.2. Retail Pharmacies

        5.10.3. Online Pharmacies

        5.10.4. Drug stores

    5.11. Drivers and Restraints: Impact Analysis

    5.12. Market Attractiveness Analysis

        5.12.1. By Country

        5.12.2. By Drug Class

        5.12.3. By Application

        5.12.4. By End User

    5.13. Key Representative Market Participants

    5.14. Key Participants Market Presence (Intensity Map)

6. Western Europe Prefilled Syringes Drug Molecules Market Analysis 2012–2021 and Forecast 2022–2028

    6.1. Introduction

    6.2. Regional Market Dynamics

        6.2.1. Drivers

        6.2.2. Restraints

        6.2.3. Trends

    6.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        6.3.1. United Kingdom

        6.3.2. Germany

        6.3.3. France

        6.3.4. Italy

        6.3.5. Spain

        6.3.6. Nordic Region

        6.3.7. Rest of Western Europe

    6.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

        6.4.1. United Kingdom

        6.4.2. Germany

        6.4.3. France

        6.4.4. Italy

        6.4.5. Spain

        6.4.6. Nordic Region

        6.4.7. Rest of Western Europe

    6.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012–2021

        6.5.1. Vaccines

        6.5.2. Insulin

        6.5.3. Adrenaline

        6.5.4. Opioids

        6.5.5. Others

    6.6. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028

        6.6.1. Vaccines

        6.6.2. Insulin

        6.6.3. Adrenaline

        6.6.4. Opioids

        6.6.5. Others

    6.7. Historical Market Size (US$ Mn) Analysis By Application , 2012-2021

        6.7.1. Cardiovascular Diseases

        6.7.2. Diabetes

        6.7.3. Immunization

        6.7.4. Pain Management

        6.7.5. Others

    6.8. Market Size (US$ Mn) Forecast By Application , 2022-2028

        6.8.1. Cardiovascular Diseases

        6.8.2. Diabetes

        6.8.3. Immunization

        6.8.4. Pain Management

        6.8.5. Others

    6.9. Historical Market Size (US$ Mn) Analysis By End User, 2012–2021

        6.9.1. Hospital Pharmacies

        6.9.2. Retail Pharmacies

        6.9.3. Online Pharmacies

        6.9.4. Drug stores

    6.10. Market Size (US$ Mn) Forecast By End User, 2022–2028

        6.10.1. Hospital Pharmacies

        6.10.2. Retail Pharmacies

        6.10.3. Online Pharmacies

        6.10.4. Drug stores

    6.11. Drivers and Restraints: Impact Analysis

    6.12. Market Attractiveness Analysis

        6.12.1. By Country

        6.12.2. By Drug Class

        6.12.3. By Application

        6.12.4. By End User

    6.13. Key Representative Market Participants

    6.14. Key Participants Market Presence (Intensity Map)

7. Eastern Europe Prefilled Syringes Drug Molecules Market Analysis 2012–2021 and Forecast 2022–2028

    7.1. Introduction

    7.2. Regional Market Dynamics

        7.2.1. Drivers

        7.2.2. Restraints

        7.2.3. Trends

    7.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        7.3.1. Russia

        7.3.2. Poland

        7.3.3. Rest of Eastern Europe

    7.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

        7.4.1. Russia

        7.4.2. Poland

        7.4.3. Rest of Eastern Europe

    7.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012–2022

        7.5.1. Vaccines

        7.5.2. Insulin

        7.5.3. Adrenaline

        7.5.4. Opioids

        7.5.5. Others

    7.6. Market Size (US$ Mn) Forecast By Drug Class, 2022–2028

        7.6.1. Vaccines

        7.6.2. Insulin

        7.6.3. Adrenaline

        7.6.4. Opioids

        7.6.5. Others

    7.7. Historical Market Size (US$ Mn) Analysis By Application , 2012-2022

        7.7.1. Cardiovascular Diseases

        7.7.2. Diabetes

        7.7.3. Immunization

        7.7.4. Pain Management

        7.7.5. Others

    7.8. Market Size (US$ Mn) Forecast By Application , 2022-2028

        7.8.1. Cardiovascular Diseases

        7.8.2. Diabetes

        7.8.3. Immunization

        7.8.4. Pain Management

        7.8.5. Others

    7.9. Historical Market Size (US$ Mn) Analysis By End User, 2012–2022

        7.9.1. Hospital Pharmacies

        7.9.2. Retail Pharmacies

        7.9.3. Online Pharmacies

        7.9.4. Drug stores

    7.10. Market Size (US$ Mn) Forecast By End User, 2022–2028

        7.10.1. Hospital Pharmacies

        7.10.2. Retail Pharmacies

        7.10.3. Online Pharmacies

        7.10.4. Drug stores

    7.11. Drivers and Restraints: Impact Analysis

    7.12. Market Attractiveness Analysis

        7.12.1. By Country

        7.12.2. By Drug Class

        7.12.3. By Application

        7.12.4. By End User

    7.13. Key Representative Market Participants

    7.14. Key Participants Market Presence (Intensity Map)

8. Asia Pacific Excluding Japan Prefilled Syringes Drug Molecules Market Analysis 2012–2021 and Forecast 2022–2028

    8.1. Introduction

    8.2. Regional Market Dynamics

        8.2.1. Drivers

        8.2.2. Restraints

        8.2.3. Trends

    8.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        8.3.1. China

        8.3.2. India

        8.3.3. Australia and New Zealand

        8.3.4. ASEAN

        8.3.5. Rest of APEJ

    8.4. Market Size (US$ Mn) Forecast By Country, 2022-2028

        8.4.1. China

        8.4.2. India

        8.4.3. Australia and New Zealand

        8.4.4. ASEAN

        8.4.5. Rest of APEJ

    8.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012–2018

        8.5.1. Vaccines

        8.5.2. Insulin

        8.5.3. Adrenaline

        8.5.4. Opioids

        8.5.5. Others

    8.6. Market Size (US$ Mn) Forecast By Drug Class, 2018–2028

        8.6.1. Vaccines

        8.6.2. Insulin

        8.6.3. Adrenaline

        8.6.4. Opioids

        8.6.5. Others

    8.7. Historical Market Size (US$ Mn) Analysis By Application , 2012-2018

        8.7.1. Cardiovascular Diseases

        8.7.2. Diabetes

        8.7.3. Immunization

        8.7.4. Pain Management

        8.7.5. Others

    8.8. Market Size (US$ Mn) Forecast By Application , 2018-2028

        8.8.1. Cardiovascular Diseases

        8.8.2. Diabetes

        8.8.3. Immunization

        8.8.4. Pain Management

        8.8.5. Others

    8.9. Historical Market Size (US$ Mn) Analysis By End User, 2012–2018

        8.9.1. Hospital Pharmacies

        8.9.2. Retail Pharmacies

        8.9.3. Online Pharmacies

        8.9.4. Drug stores

    8.10. Market Size (US$ Mn) Forecast By End User, 2018–2028

        8.10.1. Hospital Pharmacies

        8.10.2. Retail Pharmacies

        8.10.3. Online Pharmacies

        8.10.4. Drug stores

    8.11. Drivers and Restraints: Impact Analysis

    8.12. Market Attractiveness Analysis

        8.12.1. By Country

        8.12.2. By Drug Class

        8.12.3. By Application

        8.12.4. By End User

    8.13. Key Representative Market Participants

    8.14. Key Participants Market Presence (Intensity Map)

9. Japan Prefilled Syringes Drug Molecules Market Analysis 2012–2021 and Forecast 2022–2028

    9.1. Introduction

    9.2. Regional Market Dynamics

        9.2.1. Drivers

        9.2.2. Restraints

        9.2.3. Trends

    9.3. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012–2018

        9.3.1. Vaccines

        9.3.2. Insulin

        9.3.3. Adrenaline

        9.3.4. Opioids

        9.3.5. Others

    9.4. Market Size (US$ Mn) Forecast By Drug Class, 2018–2028

        9.4.1. Vaccines

        9.4.2. Insulin

        9.4.3. Adrenaline

        9.4.4. Opioids

        9.4.5. Others

    9.5. Historical Market Size (US$ Mn) Analysis By Application , 2012-2018

        9.5.1. Cardiovascular Diseases

        9.5.2. Diabetes

        9.5.3. Immunization

        9.5.4. Pain Management

        9.5.5. Others

    9.6. Market Size (US$ Mn) Forecast By Application , 2018-2028

        9.6.1. Cardiovascular Diseases

        9.6.2. Diabetes

        9.6.3. Immunization

        9.6.4. Pain Management

        9.6.5. Others

    9.7. Historical Market Size (US$ Mn) Analysis By End User, 2012–2018

        9.7.1. Hospital Pharmacies

        9.7.2. Retail Pharmacies

        9.7.3. Online Pharmacies

        9.7.4. Drug stores

    9.8. Market Size (US$ Mn) Forecast By End User, 2018–2028

        9.8.1. Hospital Pharmacies

        9.8.2. Retail Pharmacies

        9.8.3. Online Pharmacies

        9.8.4. Drug stores

    9.9. Drivers and Restraints: Impact Analysis

    9.10. Market Attractiveness Analysis

        9.10.1. By Drug Class

        9.10.2. By Application

        9.10.3. By End User

    9.11. Key Representative Market Participants

    9.12. Key Participants Market Presence (Intensity Map)

10. Middle East and Africa Prefilled Syringes Drug Molecules Market Analysis 2012–2021 and Forecast 2022–2028

    10.1. Introduction

    10.2. Regional Market Dynamics

        10.2.1. Drivers

        10.2.2. Restraints

        10.2.3. Trends

    10.3. Historical Market Size (US$ Mn) By Country, 2012-2021

        10.3.1. GCC Countries

        10.3.2. South Africa

        10.3.3. Rest of MEA

    10.4. Market Size (US$ Mn) Forecast By Country, , 2022–2028

        10.4.1. GCC Countries

        10.4.2. South Africa

        10.4.3. Rest of MEA

    10.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2012–20110

        10.5.1. Vaccines

        10.5.2. Insulin

        10.5.3. Adrenaline

        10.5.4. Opioids

        10.5.5. Others

    10.6. Market Size (US$ Mn) Forecast By Drug Class, 20110–20210

        10.6.1. Vaccines

        10.6.2. Insulin

        10.6.3. Adrenaline

        10.6.4. Opioids

        10.6.5. Others

    10.7. Historical Market Size (US$ Mn) Analysis By Application , 2012-20110

        10.7.1. Cardiovascular Diseases

        10.7.2. Diabetes

        10.7.3. Immunization

        10.7.4. Pain Management

        10.7.5. Others

    10.8. Market Size (US$ Mn) Forecast By Application , 20110-20210

        10.8.1. Cardiovascular Diseases

        10.8.2. Diabetes

        10.8.3. Immunization

        10.8.4. Pain Management

        10.8.5. Others

    10.9. Historical Market Size (US$ Mn) Analysis By End User, 2012–20110

        10.9.1. Hospital Pharmacies

        10.9.2. Retail Pharmacies

        10.9.3. Online Pharmacies

        10.9.4. Drug stores

    10.10. Market Size (US$ Mn) Forecast By End User, 20110–20210

        10.10.1. Hospital Pharmacies

        10.10.2. Retail Pharmacies

        10.10.3. Online Pharmacies

        10.10.4. Drug stores

    10.11. Drivers and Restraints: Impact Analysis

    10.12. Market Attractiveness Analysis

        10.12.1. By Country

        10.12.2. By Drug Class

        10.12.3. By Application

        10.12.4. By End User

    10.13. Key Representative Market Participants

    10.14. Key Participants Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

    13.1. Market Structure (2021)

    13.2. Competition Dashboard

    13.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

        13.3.1. Amgen Inc.

        13.3.2. Teva Pharmaceutical Industries Ltd. 

        13.3.3. AstraZeneca plc

        13.3.4. Mylan N.V. 

        13.3.5. Pfizer, Inc.

        13.3.6. Fresenius Kabi AG 

        13.3.7. Johnson & Johnson

        13.3.8. Sanofi 

        13.3.9. Merck & Co. Inc. 

        13.3.10. Novartis AG

14. Global Prefilled Syringes Drug Molecules Market Analysis 2012–2021 and Forecast 2022–2028, By Region

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Mn) By Region

        14.2.1. North America

        14.2.2. Latin America

        14.2.3. Western Europe

        14.2.4. Eastern Europe

        14.2.5. Asia Pacific Excluding Japan

        14.2.6. Japan

        14.2.7. Middle East and Africa

    14.3. Market Size (US$ Mn) Forecast By Region

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Western Europe

        14.3.4. Eastern Europe

        14.3.5. Asia Pacific Excluding Japan

        14.3.6. Japan

        14.3.7. Middle East and Africa

    14.4. Market Attractiveness Analysis By Region

15. Global Prefilled Syringes Drug Molecules Market Analysis 2012–2021 and Forecast 2022–2028, By Drug Class

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) By Drug Class, 2012-2021

        15.2.1. Vaccines

        15.2.2. Insulin

        15.2.3. Adrenaline

        15.2.4. Opioids

        15.2.5. Others

    15.3. Market Size (US$ Mn) and Forecast By Drug Class, 2022-2028

        15.3.1. Vaccines

        15.3.2. Insulin

        15.3.3. Adrenaline

        15.3.4. Opioids

        15.3.5. Others

    15.4. Market Attractiveness Analysis By Drug Class

16. Global Prefilled Syringes Drug Molecules Market Analysis 2012–2021 and Forecast 2022–2028, By Application 

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) By Application , 2012-2021

        16.2.1. Cardiovascular Diseases

        16.2.2. Diabetes

        16.2.3. Immunization

        16.2.4. Pain Management

        16.2.5. Others

    16.3. Market Size (US$ Mn) and Forecast By Application , 2022-2028

        16.3.1. Cardiovascular Diseases

        16.3.2. Diabetes

        16.3.3. Immunization

        16.3.4. Pain Management

        16.3.5. Others

    16.4. Market Attractiveness Analysis By Application 

17. Global Prefilled Syringes Drug Molecules Market Analysis 2012–2022 and Forecast 2022–2028, By End User 

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) By End User , 2012-2022

        17.2.1. Hospital Pharmacies

        17.2.2. Retail Pharmacies

        17.2.3. Online Pharmacies

        17.2.4. Drug stores

    17.3. Market Size (US$ Mn) and Forecast By End User , 2022-2028

        17.3.1. Hospital Pharmacies

        17.3.2. Retail Pharmacies

        17.3.3. Online Pharmacies

        17.3.4. Drug stores

    17.4. Market Attractiveness Analysis By End User 

18. Global Prefilled Syringes Drug Molecules Market Analysis 2012–2021 and Forecast 2022–2028

    18.1. Market Size and Y-o-Y Growth

    18.2. Absolute $ Opportunity

19. Assumptions and Acronyms Used

20. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Country

Table 02: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Drug Class 

Table 03: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Application

Table 04: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By End User

Table 05: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Country

Table 06: Latin America Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Drug Class 

Table 07: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Application

Table 08: Latin America Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By End User

Table 09: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Country

Table 10: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Drug Class 

Table 11: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Application

Table 12: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By End User

Table 13: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Country

Table 14: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Drug Class 

Table 15: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Application

Table 16: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By End User

Table 17: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Country

Table 18: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Drug Class 

Table 19: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Application

Table 20: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By End User

Table 21: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Drug Class 

Table 22: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Application

Table 23: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By End User

Table 24: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Country

Table 25: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Drug Class 

Table 26: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Application

Table 27: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By End User

Table 28: Global Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Region

Table 29: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Drug Class 

Table 30: Global Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By Application

Table 31: Global Prefilled Syringes Drug Molecules Market Size (US$ Mn) Analysis 2012–2021 and Forecast 2017–2028, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: North America Prefilled Syringes Drug Molecules Market Value Share By Drug Class  (2017E)

Figure 02: North America Prefilled Syringes Drug Molecules Market Value Share By Application (2017E)

Figure 03: North America Prefilled Syringes Drug Molecules Market Value Share By End User (2017E)

Figure 04: North America Prefilled Syringes Drug Molecules Market Value Share By Country (2017E)

Figure 05: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) Analysis, 2012–2021

Figure 06: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2028

Figure 11: U.S. Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) Analysis, 2012–2021

Figure 12: U.S. Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2028

Figure 13: Canada Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) Analysis, 2012–2021

Figure 14: Canada Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2028

Figure 15: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Vaccines, 2012–2021

Figure 16: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Vaccines, 2017–2028

Figure 17: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Insulin, 2012–2021

Figure 18: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Insulin, 2017–2028

Figure 19: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Adrenaline, 2012–2021

Figure 20: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Adrenaline, 2017–2028

Figure 21: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Opioids, 2012–2021

Figure 22: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Opioids, 2017–2028

Figure 23: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 24: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 25: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Cardiovascular Diseases, 2012–2021

Figure 26: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Cardiovascular Diseases, 2017–2028

Figure 27: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Diabetes, 2012–2021

Figure 28: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Diabetes, 2017–2028

Figure 29: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Immunization, 2012–2021

Figure 30: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Immunization, 2017–2028

Figure 31: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Pain Management, 2012–2021

Figure 32: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Pain Management, 2017–2028

Figure 33: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 34: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 35: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Hospital Pharmacies, 2012–2021

Figure 36: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospital Pharmacies, 2017–2028

Figure 37: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Retail Pharmacies, 2012–2021

Figure 38: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Retail Pharmacies, 2017–2028

Figure 39: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Online Pharmacies, 2012–2021

Figure 40: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Online Pharmacies, 2017–2028

Figure 41: North America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Drug Stores, 2012–2021

Figure 42: North America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Drug Stores, 2017–2028

Figure 43: North America Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Drug Class , 2017–2028 

Figure 44: North America Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Application, 2017–2028 

Figure 45: North America Prefilled Syringes Drug Molecules Market Attractiveness Analysis By End User, 2017–2028 

Figure 46: North America Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Country, 2017–2028 

Figure 47: Latin America  Prefilled Syringes Drug Molecules Market Value Share By Drug Class  (2017E)

Figure 48: Latin America  Prefilled Syringes Drug Molecules Market Value Share By Application (2017E)

Figure 49: Latin America  Prefilled Syringes Drug Molecules Market Value Share By End User (2017E)

Figure 50: Latin America  Prefilled Syringes Drug Molecules Market Value Share By Country (2017E)

Figure 51: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) Analysis, 2012–2021

Figure 52: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2028

Figure 53: Brazil Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 54: Brazil Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 55: Mexico Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 56: Mexico Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 57: Rest of Latin America Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 58: Rest of Latin America Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 59: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Vaccines, 2012–2021

Figure 60: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Vaccines, 2017–2028

Figure 61: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Insulin, 2012–2021

Figure 62: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Insulin, 2017–2028

Figure 63: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Adrenaline, 2012–2021

Figure 64: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Adrenaline, 2017–2028

Figure 65: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Opioids, 2012–2021

Figure 66: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Opioids, 2017–2028

Figure 67: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 68: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 69: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Cardiovascular Diseases, 2012–2021

Figure 70: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Cardiovascular Diseases, 2017–2028

Figure 71: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Diabetes, 2012–2021

Figure 72: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Diabetes, 2017–2028

Figure 73: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Immunization, 2012–2021

Figure 74: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Immunization, 2017–2028

Figure 75: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Pain Management, 2012–2021

Figure 76: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Pain Management, 2017–2028

Figure 77: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 78: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 79: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Hospital Pharmacies, 2012–2021

Figure 80: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospital Pharmacies, 2017–2028

Figure 81: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Retail Pharmacies, 2012–2021

Figure 82: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Retail Pharmacies, 2017–2028

Figure 83: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Online Pharmacies, 2012–2021

Figure 84: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Online Pharmacies, 2017–2028

Figure 85: Latin America  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Drug Stores, 2012–2021

Figure 86: Latin America  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Drug Stores, 2017–2028

Figure 87: Latin America  Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Drug Class , 2017–2028 

Figure 88: Latin America  Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Application, 2017–2028 

Figure 89: Latin America  Prefilled Syringes Drug Molecules Market Attractiveness Analysis By End User, 2017–2028 

Figure 90: Latin America  Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Country, 2017–2028 

Figure 91: Western Europe Prefilled Syringes Drug Molecules Market Value Share By Drug Class  (2017E)

Figure 92: Western Europe Prefilled Syringes Drug Molecules Market Value Share By Application (2017E)

Figure 93: Western Europe Prefilled Syringes Drug Molecules Market Value Share By End User (2017E)

Figure 94: Western Europe Prefilled Syringes Drug Molecules Market Value Share By Country (2017E)

Figure 95: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) Analysis, 2012–2021

Figure 96: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2028

Figure 97: U.K. Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By 2012–2021

Figure 98: U.K. Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) 2017–2028

Figure 99: Germany Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 100: Germany Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 101: France Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By, 2012–2021

Figure 102: France Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 103: Italy Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 104: Italy Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 105: Spain Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 106: Spain Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 107: Nordics Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 108: Nordics Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 109: Rest of Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 110: Rest of Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 111: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Vaccines, 2012–2021

Figure 112: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Vaccines, 2017–2028

Figure 113: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Insulin, 2012–2021

Figure 114: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Insulin, 2017–2028

Figure 115: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Adrenaline, 2012–2021

Figure 116: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Adrenaline, 2017–2028

Figure 117: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Opioids, 2012–2021

Figure 118: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Opioids, 2017–2028

Figure 119: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 120: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 121: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Cardiovascular Diseases, 2012–2021

Figure 122: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Cardiovascular Diseases, 2017–2028

Figure 123: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Diabetes, 2012–2021

Figure 124: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Diabetes, 2017–2028

Figure 125: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Immunization, 2012–2021

Figure 126: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Immunization, 2017–2028

Figure 127: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Pain Management, 2012–2021

Figure 128: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Pain Management, 2017–2028

Figure 129: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 130: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 131: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Hospital Pharmacies, 2012–2021

Figure 132: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospital Pharmacies, 2017–2028

Figure 133: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Retail Pharmacies, 2012–2021

Figure 134: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Retail Pharmacies, 2017–2028

Figure 135: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Online Pharmacies, 2012–2021

Figure 136: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Online Pharmacies, 2017–2028

Figure 137: Western Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Drug Stores, 2012–2021

Figure 138: Western Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Drug Stores, 2017–2028

Figure 139: Western Europe Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Drug Class , 2017–2028 

Figure 140: Western Europe Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Application, 2017–2028 

Figure 141: Western Europe Prefilled Syringes Drug Molecules Market Attractiveness Analysis By End User, 2017–2028 

Figure 142: Western Europe Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Country, 2017–2028 

Figure 143: Eastern Europe Prefilled Syringes Drug Molecules Market Value Share By Drug Class  (2017E)

Figure 144: Eastern Europe Prefilled Syringes Drug Molecules Market Value Share By Application (2017E)

Figure 145: Eastern Europe Prefilled Syringes Drug Molecules Market Value Share By End User(2017)

Figure 146: Eastern Europe Prefilled Syringes Drug Molecules Market Value Share By Country (2017)

Figure 147: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) Analysis, 2012–2021

Figure 148: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2028

Figure 149: Russia Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 150: Russia Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 151: Poland Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 152: Poland Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 153: Rest of Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 154: Rest of Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 155: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Vaccines, 2012–2021

Figure 156: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Vaccines, 2017–2028

Figure 157: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Insulin, 2012–2021

Figure 158: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Insulin, 2017–2028

Figure 159: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Adrenaline, 2012–2021

Figure 160: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Adrenaline, 2017–2028

Figure 161: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Opioids, 2012–2021

Figure 162: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Opioids, 2017–2028

Figure 163: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 164: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 165: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Cardiovascular Diseases, 2012–2021

Figure 166: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Cardiovascular Diseases, 2017–2028

Figure 167: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Diabetes, 2012–2021

Figure 168: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Diabetes, 2017–2028

Figure 169: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Immunization, 2012–2021

Figure 170: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Immunization, 2017–2028

Figure 171: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Pain Management, 2012–2021

Figure 172: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Pain Management, 2017–2028

Figure 173: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 174: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 175: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Hospital Pharmacies, 2012–2021

Figure 176: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospital Pharmacies, 2017–2028

Figure 177: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Retail Pharmacies, 2012–2021

Figure 178: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Retail Pharmacies, 2017–2028

Figure 179: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Online Pharmacies, 2012–2021

Figure 180: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Online Pharmacies, 2017–2028

Figure 181: Eastern Europe Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Drug Stores, 2012–2021

Figure 182: Eastern Europe Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Drug Stores, 2017–2028

Figure 183: Eastern Europe Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Drug Class , 2017–2028 

Figure 184: Eastern Europe Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Application, 2017–2028 

Figure 185: Eastern Europe Prefilled Syringes Drug Molecules Market Attractiveness Analysis By End User, 2017–2028 

Figure 186: Eastern Europe Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Country, 2017–2028 

Figure 187: APEJ Prefilled Syringes Drug Molecules Market Value Share By Drug Class  (2017E)

Figure 188: APEJ Prefilled Syringes Drug Molecules Market Value Share By Application (2017E)

Figure 189: APEJ Prefilled Syringes Drug Molecules Market Value Share By End User (2017E)

Figure 190: APEJ Prefilled Syringes Drug Molecules Market Value Share By Country (2017E)

Figure 191: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) Analysis, 2012–2021

Figure 192: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2028

Figure 193: China Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 194: China Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 195: India Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 196: India Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 197: Australia & New Zealand Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 198: Australia & New Zealand Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 199: ASEAN Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By, 2012–2021

Figure 200: ASEAN Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 201: Rest of APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 202: Rest of APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 203: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Vaccines, 2012–2021

Figure 204: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Vaccines, 2017–2028

Figure 205: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Insulin, 2012–2021

Figure 206: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Insulin, 2017–2028

Figure 207: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Adrenaline, 2012–2021

Figure 208: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Adrenaline, 2017–2028

Figure 209: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Opioids, 2012–2021

Figure 210: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Opioids, 2017–2028

Figure 211: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 212: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 213: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Cardiovascular Diseases, 2012–2021

Figure 214: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Cardiovascular Diseases, 2017–2028

Figure 215: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Diabetes, 2012–2021

Figure 216: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Diabetes, 2017–2028

Figure 217: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Immunization, 2012–2021

Figure 218: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Immunization, 2017–2028

Figure 219: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Pain Management, 2012–2021

Figure 220: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Pain Management, 2017–2028

Figure 221: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 222: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 223: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Hospital Pharmacies, 2012–2021

Figure 224: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospital Pharmacies, 2017–2028

Figure 225: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Retail Pharmacies, 2012–2021

Figure 226: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Retail Pharmacies, 2017–2028

Figure 227: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Online Pharmacies, 2012–2021

Figure 228: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Online Pharmacies, 2017–2028

Figure 229: APEJ Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Drug Stores, 2012–2021

Figure 230: APEJ Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Drug Stores, 2017–2028

Figure 231: APEJ Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Drug Class, 2017–2028 

Figure 232: APEJ Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Application, 2017–2028 

Figure 233: APEJ Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Therapeutic Area, 2017–2028 

Figure 234: APEJ Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Country, 2017–2028 

Figure 235: Japan  Prefilled Syringes Drug Molecules Market Value Share By Drug Class (2017)

Figure 236: Japan  Prefilled Syringes Drug Molecules Market Value Share By Application (2017)

Figure 237: Japan  Prefilled Syringes Drug Molecules Market Value Share By End User (2017)

Figure 238: Japan  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) Analysis, 2012–2021

Figure 239: Japan  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 240: Japan Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Vaccines, 2012–2021

Figure 241: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Vaccines, 2017–2028

Figure 242: Japan Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Insulin, 2012–2021

Figure 243: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Insulin, 2017–2028

Figure 244: Japan Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Adrenaline, 2012–2021

Figure 245: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Adrenaline, 2017–2028

Figure 246: Japan Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Opioids, 2012–2021

Figure 247: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Opioids, 2017–2028

Figure 248: Japan Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 249: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 250: Japan Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Cardiovascular Diseases, 2012–2021

Figure 251: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Cardiovascular Diseases, 2017–2028

Figure 252: Japan Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Diabetes, 2012–2021

Figure 253: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Diabetes, 2017–2028

Figure 254: Japan Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Immunization, 2012–2021

Figure 255: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Immunization, 2017–2028

Figure 256: Japan Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Pain Management, 2012–2021

Figure 257: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Pain Management, 2017–2028

Figure 258: Japan Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 259: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 260: Japan  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Hospital Pharmacies, 2012–2021

Figure 261: Japan  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospital Pharmacies, 2017–2028

Figure 262: Japan Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Retail Pharmacies, 2012–2021

Figure 263: Japan  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Retail Pharmacies, 2017–2028

Figure 264: Japan Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Online Pharmacies, 2012–2021

Figure 265: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Online Pharmacies, 2017–2028

Figure 266: Japan Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Drug Stores, 2012–2021

Figure 267: Japan Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Drug Stores, 2017–2028

Figure 268: Japan Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Drug Class, 2017–2028 

Figure 269: Japan Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Application, 2017–2028 

Figure 270: Japan Prefilled Syringes Drug Molecules Market Attractiveness Analysis By End User, 2017–2028 

Figure 271: Middle East & Africa Prefilled Syringes Drug Molecules Market Value Share By Drug Class  (2017E)

Figure 272: Middle East & Africa Prefilled Syringes Drug Molecules Market Value Share By Application (2017E)

Figure 273: Middle East & Africa Prefilled Syringes Drug Molecules Market Value Share By End User (2017E)

Figure 274: Middle East & Africa Prefilled Syringes Drug Molecules Market Value Share By Country (2017E)

Figure 275: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) Analysis, 2012–2021

Figure 276: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2028

Figure 277: GCC Countries Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 278: GCC Countries Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 279: South Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 280: South Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 281: Rest of Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn), 2012–2021

Figure 282:Rest of Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2028

Figure 283: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Vaccines, 2012–2021

Figure 284: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Vaccines, 2017–2028

Figure 285: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Insulin, 2012–2021

Figure 286: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Insulin, 2017–2028

Figure 287: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Adrenaline, 2012–2021

Figure 288: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Adrenaline, 2017–2028

Figure 289: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Opioids, 2012–2021

Figure 290: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Opioids, 2017–2028

Figure 291: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 292: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 293: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Cardiovascular Diseases, 2012–2021

Figure 294: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Cardiovascular Diseases, 2017–2028

Figure 295: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Diabetes, 2012–2021

Figure 296: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Diabetes, 2017–2028

Figure 297: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Immunization, 2012–2021

Figure 298: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Immunization, 2017–2028

Figure 299: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Pain Management, 2012–2021

Figure 300: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Pain Management, 2017–2028

Figure 301: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 302: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 303: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Hospital Pharmacies, 2012–2021

Figure 304: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospital Pharmacies, 2017–2028

Figure 305: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Retail Pharmacies, 2012–2021

Figure 306: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Retail Pharmacies, 2017–2028

Figure 307: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Online Pharmacies, 2012–2021

Figure 308: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Online Pharmacies, 2017–2028

Figure 309: Middle East & Africa Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Drug Stores, 2012–2021

Figure 310: Middle East & Africa Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Drug Stores, 2017–2028

Figure 311: Middle East & Africa Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Drug Class, 2017–2028 

Figure 312: Middle East & Africa Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Application, 2017–2028 

Figure 313: Middle East & Africa Prefilled Syringes Drug Molecules Market Attractiveness Analysis By End User, 2017–2028 

Figure 314: Middle East & Africa Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Country, 2017–2028 

Figure 315: Global Prefilled Syringes Drug Molecules Market Y-o-Y Growth (%) 2017–2028, By Region

Figure 316: Global Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Region, 2017–2028 

Figure 317: Global Prefilled Syringes Drug Molecules Market Y-o-Y Growth (%) 2017–2028, By Drug Class

Figure 318: Global Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Vaccines, 2012–2021

Figure 319: Global Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Vaccines, 2017–2028

Figure 320: Global Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Insulin, 2012–2021

Figure 321: Global Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Insulin, 2017–2028

Figure 322: Global Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Adrenaline, 2012–2021

Figure 323: Global Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Adrenaline, 2017–2028

Figure 324: Global Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Opioids, 2012–2021

Figure 325: Global Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Opioids, 2017–2028

Figure 326: Global Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 327: Global Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 328: Global Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Drug Class, 2017–2028 

Figure 329: Global Prefilled Syringes Drug Molecules Market Y-o-Y Growth (%) 2017–2028, By Application

Figure 330: Global Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Cardiovascular Diseases, 2012–2021

Figure 331: Global Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Cardiovascular Diseases, 2017–2028

Figure 332: Global Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Diabetes, 2012–2021

Figure 333: Global Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Diabetes, 2017–2028

Figure 334: Global Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Immunization, 2012–2021

Figure 335: Global Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Immunization, 2017–2028

Figure 336: Global Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Pain Management, 2012–2021

Figure 337: Global Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Pain Management, 2017–2028

Figure 338: Global Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Others, 2012–2021

Figure 339: Global Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2017–2028

Figure 340: Global Prefilled Syringes Drug Molecules Market Attractiveness Analysis By Application, 2017–2028 

Figure 341: Global Prefilled Syringes Drug Molecules Market Y-o-Y Growth (%) 2017–2028, By End User

Figure 342: Global  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Hospital Pharmacies, 2012–2021

Figure 343: Global   Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Hospital Pharmacies, 2017–2028

Figure 344: Global Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Retail Pharmacies, 2012–2021

Figure 345: Global   Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Retail Pharmacies, 2017–2028

Figure 346: Global  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Online Pharmacies, 2012–2021

Figure 347: Global  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Online Pharmacies, 2017–2028

Figure 348: Global  Prefilled Syringes Drug Molecules Historical Market Size (US$ Mn) By Drug Stores, 2012–2021

Figure 349: Global  Prefilled Syringes Drug Molecules Market Size (US$ Mn) & Y-o-Y Growth (%) By Drug Stores, 2017–2028

Figure 350: Global Prefilled Syringes Drug Molecules Market Attractiveness Analysis By End User, 2017–2028 

Figure 351: Global Prefilled Syringes Drug Molecules Market Value Analysis and Forecast, 2021–2028 (US$ Mn)

Figure 352: Global Prefilled Syringes Drug Molecules Market Absolute $ Opportunity (US$ Mn), 2012–2021

Figure 353: Global Prefilled Syringes Drug Molecules Market Absolute $ Opportunity (US$ Mn), 2021–2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Injectable Benzodiazepine Market

Published : June 2020

Healthcare

GCC Syringes and Needles Market

Published : December 2021

Healthcare

Infusion Pumps Market

Published : February 2022

Healthcare

Injectable Drug Delivery Market

Published : December 2021

Google translate

Prefilled Syringes Drug Molecules Market